New onset of hypertension associated with immune checkpoint inhibitor therapy in cancer patients
ICI therapy is significantly associated with an increased risk of developing hypertension. These findings support the need for routine cardiovascular monitoring in patients receiving ICI treatment.
Authors
- HangYu Watson (ORCID: https://orcid.org/0009-0003-9838-8794)
- Brijesh Patel (ORCID: https://orcid.org/0000-0001-8973-8228)
- Nolan Holley (ORCID: https://orcid.org/0000-0001-5322-4962)
- Tabot Ntoung Nkongho
Institutions
- West Virginia University (US)
- Indiana University (US)
Publication Details
- Journal
- Immunotherapy
- Published
- 2025-05-03
- DOI
- https://doi.org/10.1080/1750743x.2025.2504868
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.14